UPLOAD Filing
Immix Biopharma, Inc.
Date: Jan. 16, 2026 · CIK: 0001873835 · Accession: 0000000000-26-000603
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-292665
Letter
January 16, 2026 Ilya Rachman Chief Executive Officer Immix Biopharma, Inc. 11400 West Olympic Blvd., Suite 200 Los Angeles, CA 90064 Re:Immix Biopharma, Inc. Registration Statement on Form S-3 Filed January 9, 2026 File No. 333-292665 Dear Ilya Rachman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Melissa Murawsky, Esq.
Show Raw Text
January 16, 2026
Ilya Rachman
Chief Executive Officer
Immix Biopharma, Inc.
11400 West Olympic Blvd., Suite 200
Los Angeles, CA 90064
Re:Immix Biopharma, Inc.
Registration Statement on Form S-3
Filed January 9, 2026
File No. 333-292665
Dear Ilya Rachman:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Melissa Murawsky, Esq.